城發環境(000885.SZ)配股 8月5日停牌
格隆匯 8 月 4日丨城發環境(000885.SZ)公佈,此次配股簡稱:城發A1配;配股代碼:080885;配股價格:8.00元/股。
此次配股繳款起止日期:2020年8月5日(R+1日)至2020年8月11日(R+5日)的深圳證券交易所正常交易時間,請股東注意申購時間。
此次配股網上認購期間(即繳款起止日期間:2020年8月5日至2020年8月11日)公司股票停牌,2020年8月12日(R+6日)中國證券登記結算有限責任公司深圳分公司(“登記公司”)對此次配股進行網上清算,公司股票繼續停牌,2020年8月13日(R+7日)公告配股結果,公司股票復牌交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.